Kagocel

N/A

Report date: 2023/02/26 21:49:42
NME

Base Information

Drug NameKagocel
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-23 stimulantsImmunomodulators
TargetsInterleukin-23Toll-like receptorC-type lectin domain family 7 member A
Therapy Area/IndicationsRespirovirus InfectionsInfluenza, HumanRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesNearmedic Plus Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsRespirovirus InfectionsInfluenza, HumanRespiratory Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A